Schulhoff & CO Inc Avadel Pharmaceuticals PLC Transaction History
Schulhoff & CO Inc
- $209 Million
- Q1 2025
A detailed history of Schulhoff & CO Inc transactions in Avadel Pharmaceuticals PLC stock. As of the latest transaction made, Schulhoff & CO Inc holds 137,500 shares of AVDL stock, worth $1.31 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
137,500
Previous 137,000
0.36%
Holding current value
$1.31 Million
Previous $1.44 Million
25.23%
% of portfolio
0.52%
Previous 0.67%
Shares
4 transactions
Others Institutions Holding AVDL
# of Institutions
6Shares Held
738KCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL600KShares$5.74 Million3.14% of portfolio
-
American Portfolios Advisors Holbrook, NY500Shares$4,7800.0% of portfolio
-
American Research & Management Co.100Shares$9560.0% of portfolio
-
Exane Derivatives33Shares$3150.0% of portfolio
-
Huntington National Bank Columbus, OH1Shares$90.0% of portfolio
About AVADEL PHARMACEUTICALS PLC
- Ticker AVDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 60,581,300
- Market Cap $579M
- Description
- Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...